Mc Collum Christoferson Group LLC Virios Therapeutics, Inc. Call Options Transaction History
Mc Collum Christoferson Group LLC
- $328 Million
- Q3 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding VIRI
# of Institutions
27Shares Held
978KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA209KShares$931,6180.0% of portfolio
-
Geode Capital Management, LLC Boston, MA174KShares$778,1310.0% of portfolio
-
Ubs Group Ag152KShares$676,9340.0% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA66KShares$294,3190.0% of portfolio
-
Hrt Financial LP New York, NY57.5KShares$256,6460.0% of portfolio
About Virios Therapeutics, Inc.
- Ticker VIRI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 18,330,400
- Market Cap $81.8M
- Description
- Virios Therapeutics, Inc., a development-stage biotechnology company, focuses on developing antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It is also developing IMC...